Literature DB >> 15943582

Mutating His29, His125, His133 or His158 abolishes glycosylphosphatidylinositol-specific phospholipase D catalytic activity.

Nandita S Raikwar1, Rosario F Bowen, Mark A Deeg.   

Abstract

Glycosylphosphatidylinositol (GPI)-specific phospholipase D (GPI-PLD) specifically cleaves GPIs. This phospholipase D is a secreted protein consisting of two domains: an N-terminal catalytic domain and a predicted C-terminal b-propeller. Although the biochemical properties of GPI-PLD have been extensively studied, its catalytic site has not been identified. We hypothesized that a histidine residue(s) may play a critical role in the catalytic activity of GPI-PLD, based on the observations that (i) Zn2+, which utilizes histidine residues for binding, is required for GPI-PLD catalytic activity, (ii) a phosphohistidine intermediate is involved in phospholipase D hydrolysis of phosphatidylcholine, (iii) computer modelling suggests a catalytic site containing histidine residues, and (iv) our observation that diethyl pyrocarbonate, which modifies histidine residues, inhibits GPI-PLD catalytic activity. Individual mutation of the ten histidine residues to asparagine in the catalytic domain of murine GPI-PLD resulted in three general phenotypes: not secreted or retained (His56 or His88), secreted with catalytic activity (His34, His81, His98 or His219) and secreted without catalytic activity (His29, His125, His133 or His158). Changing His133 but not His29, His125 or His158 to Cys resulted in a mutant that retained catalytic activity, suggesting that at least His133 is involved in Zn2+ binding. His133 and His158 also retained the biochemical properties of wild-type GPI-PLD including trypsin cleavage pattern and phosphorylation by protein kinase A. Hence, His29, His125, His133 and His158 are required for GPI-PLD catalytic activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943582      PMCID: PMC1276926          DOI: 10.1042/BJ20050656

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Glycosylphosphatidylinositol-specific phospholipase D of human serum--activity modulation by naturally occurring amphiphiles.

Authors:  H Rhode; M Schulze; G A Cumme; A Göhlert; E Blume; R Bublitz; K Schilling; A Horn
Journal:  Biol Chem       Date:  2000 May-Jun       Impact factor: 3.915

Review 2.  Beta-propellers: associated functions and their role in human diseases.

Authors:  Tirso Pons; Raú Gómez; Glay Chinea; Alfonso Valencia
Journal:  Curr Med Chem       Date:  2003-03       Impact factor: 4.530

3.  Electrostatic interactions in leucine zippers: thermodynamic analysis of the contributions of Glu and His residues and the effect of mutating salt bridges.

Authors:  Daniel N Marti; Hans Rudolf Bosshard
Journal:  J Mol Biol       Date:  2003-07-11       Impact factor: 5.469

Review 4.  WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases.

Authors:  D Li; R Roberts
Journal:  Cell Mol Life Sci       Date:  2001-12       Impact factor: 9.261

5.  Calreticulin functions in vitro as a molecular chaperone for both glycosylated and non-glycosylated proteins.

Authors:  Y Saito; Y Ihara; M R Leach; M F Cohen-Doyle; D B Williams
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

6.  Zinc mining for protein domains.

Authors:  J W Schwabe; A Klug
Journal:  Nat Struct Biol       Date:  1994-06

7.  Phosphorylation decreases trypsin activation and apolipoprotein al binding to glycosylphosphatidylinositol-specific phospholipase D.

Authors:  Mark A Deeg; Rosario F Bowen
Journal:  Biochem Cell Biol       Date:  2002       Impact factor: 3.626

8.  Structural features of GPI-specific phospholipase D revealed by proteolytic fragmentation and Ca2+ binding studies.

Authors:  J Y Li; K Hollfelder; K S Huang; M G Low
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

9.  An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures.

Authors:  G Brunner; C N Metz; H Nguyen; J Gabrilove; S R Patel; M A Davitz; D B Rifkin; E L Wilson
Journal:  Blood       Date:  1994-04-15       Impact factor: 22.113

10.  Expression and secretion of glycosylphosphatidylinositol-specific phospholipase D by myeloid cell lines.

Authors:  M Xie; M G Low
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

View more
  3 in total

Review 1.  GPI-AP release in cellular, developmental, and reproductive biology.

Authors:  Yoshitaka Fujihara; Masahito Ikawa
Journal:  J Lipid Res       Date:  2015-11-22       Impact factor: 5.922

Review 2.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

3.  The wooly mutation (wly) on mouse chromosome 11 is associated with a genetic defect in Fam83g.

Authors:  Legairre A Radden; Kevin M Child; Elisabeth B Adkins; Damek V Spacek; Aaron M Feliciano; Thomas R King
Journal:  BMC Res Notes       Date:  2013-05-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.